www.law360.com/cases/59dd5989ac94675a6c000001

Janssen Pharmaceutical N.V. et al, case number 2:16-cv-06997, from California ... United States of America et al v. ... Janssen Research and Development, LLC ...

www.litigationandtrial.com/files/2016/06/Invokana-Janssen-Response.pdf

Oct 12, 2016 ... ... (S.D. Ill.), Allen v. Janssen Pharmaceuticals, Inc., et al., Case No. 3:15 ... id. at * 8–*11. In Brazil v. Janssen Research & Development LLC, No.

caselaw.findlaw.com/pa-superior-court/1889831.html

Case opinion for PA Superior Court NICHOLAS MURRAY v. JANSSEN PHARMACEUTICALS INC JOHNSON JOHNSON JANSSEN RESEARCH DEVELOPMENT LLC ... All of the cases in this mass tort action consist of male plaintiffs who allege ...... 682, 42 U.S.C. § 201 et seq. and was approved or licensed; or is generally ...

fjdefile.phila.gov/dockets/zk_fjd_public_qry_05.zp_dktrpt_frames?case_id=160503416&genrc_par1=15&genrc_par2=&call_type=H

Case Caption: HARTMAN ETAL VS JANSSEN PHARMACEUTICALS, INC. ETAL ... 8, 17, 27-OCT-2017, DEFENDANT, @9024732, JANSSEN ORTHO LLC ..... JOHNSON, JANSSEN RESEARCH & DEVELOPMENT LLC AND JANSSEN ...

www.janssen.com/research-and-development

See how Janssen tackles research and development of new drug treatments and therapies.

www.ncbi.nlm.nih.gov/pmc/articles/PMC4033110

May 3, 2013 ... All patients continued their treatment regimen through week 100 in a double- blinded manner. .... mSASSS change, by receipt of 50 mg vs 100 mg, n, 177, 122 .... AB, BH, YZ and SX are employees of Janssen Research & Development, LLC, a Johnson & Johnson ... Schett G, Coates LC, Ash ZR, et al.

www.ncbi.nlm.nih.gov/pmc/articles/PMC4033146

Feb 19, 2014 ... All other placebo patients received ustekinumab 45 mg at wk 24 and .... and anti- TNF-naive (11.9% vs 5.6%) patients within the PSUMMIT-2 study. ..... employee of Janssen Research & Development, LLC, for statistical ... McInnes IB, Kavanaugh A, Gottlieb AB, et al. on behalf of the PSUMMIT I Study Group.